When did Incyte report Q3 2025 earnings?

Incyte (INCY) reported Q3 2025 earnings on October 28, 2025 before market open.

What were Incyte's Q3 2025 revenue and EPS?

Incyte reported revenue of $1.4B and diluted EPS of $2.26 for Q3 2025.

Did Incyte beat estimates in Q3 2025?

Revenue beat the consensus estimate of $1.4B by $11.7M. EPS beat the consensus estimate of $1.66 by $0.60.

How did Incyte's Q3 2025 results compare year-over-year?

Compared to the same quarter a year prior, revenue grew 20.0% from $1.1B a year earlier and diluted EPS grew 111.2% from $1.07.

Where can I find Incyte's Q3 2025 SEC filings?

You can read the 10-Q periodic report (0000879169-25-000118) directly on SEC EDGAR. The filing index links above go to sec.gov.

Incyte INCY Q3 2025 earnings

Reported October 28, 2025 · Before market open

Revenue$1.4BBeat by $11.7M Diluted EPS$2.26Beat by $0.60

Revenue estimate$1.4B

EPS estimate$1.66

Next report

Jul 28, 2026 (In 2 weeks)

Revenue estimate$1.4B

EPS estimate$1.97

Financials

Q3 2025

Income statement

See full

Revenue$1.4B+20.0%

Gross profit$1.3B+20.4%

Operating income$443.5M+204%

Net income$424.2M+298%

EPS (diluted)$2.11+291%

Balance sheet

See full

Cash & equivalents$2.5B+88.1%

Total debt$41.3M+13.0%

Total equity$4.7B+46.7%

Total assets$6.3B+26.3%

Cash flow

See full

Operating cash flow$559.4M+79.9%

CapEx$112.0K-95.9%

Free cash flow$559.3M+81.5%

Valuation & ratios

Valuation

as of 09/30/25

See full

Market cap$16.56B+14.8%

Enterprise value$14.15B+7.6%

P/E13.9×-430×

P/S3.4×-0.1×

Profitability

See full

Gross margin92.9%+0.1pp

Operating margin30.8%+29.6pp

Net margin24.7%+23.9pp

FCF margin25.9%+23.6pp

Returns & leverage

See full

Return on equity30.4%+29.6pp

Debt / equity0×0.0×

Current ratio3.2×+1.3×

Segments

By product

See full

JAKAFI$791.1M+6.7%

OPZELURA$188.0M+35.0%

JAKAVI Royalty Revenues$125.6M+8.6%

NIKTIMVO$45.8M—

Milestone and contract revenues$45.0M—

By geography

See full

Europe$100.3M+50.9%

Other countries$4.4M+223%

By segment

See full

Reportable Segment$1.4B+20.0%

Versus estimates

Revenue

Q1 2026$1.3BBeat by $56.7M Q4 2025$1.5BBeat by $152.0M

Q3 2025$1.4BBeat by $11.7M

Q2 2025$1.2BMiss by $41.3M Q1 2025$1.1BMiss by $100.1M Q4 2024$1.2BBeat by $173.8M

Diluted EPS

Q1 2026$1.81Beat by $0.43 Q4 2025$1.80Miss by $0.10

Q3 2025$2.26Beat by $0.60

Q2 2025$1.57Beat by $0.18 Q1 2025$1.16Beat by $0.15 Q4 2024$1.43Miss by $0.14

Ask the moment Incyte reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Incyte report Q3 2025 earnings?: Incyte (INCY) reported Q3 2025 earnings on October 28, 2025 before market open.
What were Incyte's Q3 2025 revenue and EPS?: Incyte reported revenue of $1.4B and diluted EPS of $2.26 for Q3 2025.
Did Incyte beat estimates in Q3 2025?: Revenue beat the consensus estimate of $1.4B by $11.7M. EPS beat the consensus estimate of $1.66 by $0.60.
How did Incyte's Q3 2025 results compare year-over-year?: Compared to the same quarter a year prior, revenue grew 20.0% from $1.1B a year earlier and diluted EPS grew 111.2% from $1.07.
Where can I find Incyte's Q3 2025 SEC filings?: You can read the 10-Q periodic report (0000879169-25-000118) directly on SEC EDGAR. The filing index links above go to sec.gov.